Clinical Trial Update: Continuous Glucose Monitoring (CGM) Substudy of the DECIDE RCT

View source ↗

Summary

The continuous glucose monitoring (CGM) substudy of the DECIDE randomized trial has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gestational Diabetes Mellitus

Snippet

Sponsor: Ohio State University | Conditions: Gestational Diabetes Mellitus, Pregnancy, High Risk | Status: WITHDRAWN